NASDAQ:RIGL - Rigel Pharmaceuticals SEC Filings & 10K Form

$1.66
-0.01 (-0.60 %)
(As of 09/17/2019 03:49 PM ET)
Today's Range
$1.64
Now: $1.6650
$1.72
50-Day Range
$1.65
MA: $1.92
$2.36
52-Week Range
$1.60
Now: $1.6650
$3.63
Volume338,977 shs
Average Volume1.26 million shs
Market Capitalization$279.07 million
P/E RatioN/A
Dividend YieldN/A
Beta1.42

SEC Filings

Rigel Pharmaceuticals (NASDAQ:RIGL) SEC Filings

DateFilerForm TypeView
08/06/2019
7:34 PM
Rigel Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/06/2019
3:16 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
3:09 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/24/2019
4:23 PM
Katkin Keith (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:21 PM
Goodwin Bradford S (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:19 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:18 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:17 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:15 PM
LYONS GARY A (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
4:08 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
3:16 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2019
7:21 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
6:40 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2019
3:21 PM
Rigel Pharmaceuticals (Filer)
Form DEFA14A
04/09/2019
3:07 PM
Rigel Pharmaceuticals (Filer)
Form DEF 14A
04/03/2019
5:36 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2019
5:29 PM
Rigel Pharmaceuticals (Issuer)
Wasman Jane (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/26/2019
3:31 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2019
6:28 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:26 PM
Markel Stacy (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:25 PM
Lasaga Joseph (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:24 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:23 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:22 PM
Rigel Pharmaceuticals (Issuer)
VANCE DOLLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:19 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2019
6:17 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2019
8:48 AM
Rigel Pharmaceuticals (Filer)
Form CT ORDER
02/28/2019
3:02 PM
Rigel Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
3:06 PM
GREAT POINT PARTNERS LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2019
9:00 AM
Rigel Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/06/2019
4:29 PM
BlackRock Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/01/2019
4:25 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2019
5:55 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:53 PM
Lasaga Joseph (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:51 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:41 PM
Markel Stacy (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:36 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:32 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:23 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:20 PM
Rigel Pharmaceuticals (Issuer)
VANCE DOLLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2019
5:17 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2019
6:35 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2019
3:16 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:06 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2018
7:10 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2018
5:46 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/04/2018
8:00 AM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2018
5:26 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
6:48 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2018
6:02 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2018
6:49 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
6:12 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
5:16 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2018
4:18 PM
Rigel Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/08/2018
3:34 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2018
3:11 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/05/2018
5:59 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2018
6:59 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2018
6:46 PM
Rigel Pharmaceuticals (Issuer)
Schorno Dean L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/31/2018
4:10 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/18/2018
8:37 PM
Rigel Pharmaceuticals (Issuer)
RINGROSE PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:36 PM
Kotzin Brian L. (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:35 PM
MOOS WALTER H (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:31 PM
LYONS GARY A (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:29 PM
LAPOINTE ANTHONY GREGG (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:28 PM
Katkin Keith (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
8:27 PM
Goodwin Bradford S (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
3:31 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2018
6:51 PM
Lasaga Joseph (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
6:50 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
6:47 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
6:41 PM
Rigel Pharmaceuticals (Issuer)
VANCE DOLLY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
6:33 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
6:29 PM
Rigel Pharmaceuticals (Issuer)
RODRIGUEZ RAUL R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2018
3:50 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2018
3:06 PM
Rigel Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2018
8:06 PM
Duliege Anne-Marie (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2018
4:15 PM
Boxer Capital, LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G
04/20/2018
3:21 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2018
3:17 PM
Rigel Pharmaceuticals (Filer)
Form 424B5
04/18/2018
4:15 PM
Rigel Pharmaceuticals (Filer)
Form 424B5
04/04/2018
4:17 PM
Rigel Pharmaceuticals (Filer)
Form DEFA14A
04/04/2018
4:16 PM
Rigel Pharmaceuticals (Filer)
Form DEF 14A
04/02/2018
11:15 PM
Rigel Pharmaceuticals (Filer)
Form EFFECT
03/29/2018
3:33 PM
Rigel Pharmaceuticals (Filer)
Form 10-K/A
03/23/2018
5:18 PM
Markel Stacy (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/23/2018
5:08 PM
Markel Stacy (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/23/2018
4:29 PM
Rigel Pharmaceuticals (Filer)
Form PRE 14A
03/15/2018
1:41 PM
Rigel Pharmaceuticals (Filer)
Form CT ORDER
03/09/2018
4:12 PM
Rigel Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/06/2018
3:41 PM
Rigel Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2018
3:08 PM
Rigel Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2018
3:49 PM
GREAT POINT PARTNERS LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2018
8:43 AM
FMR LLC (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2018
10:47 AM
OppenheimerFunds, Inc. (Filed by)
Rigel Pharmaceuticals (Subject)
Form SC 13G/A
02/08/2018
11:09 AM
Rigel Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/26/2018
5:44 PM
Cabatuan Nelson (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2018
5:38 PM
Lasaga Joseph (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2018
5:35 PM
Masuda Esteban (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2018
5:33 PM
Mayer Eldon C. III (Reporting)
Rigel Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel